ScienceDaily: Health & Medicine News |
- Radiation and immunotherapy combination can destroy both primary and secondary tumors
- New cancer drugs could treat lethal resistant prostate cancers
- Screening method uncovers drugs that may combat deadly antibiotic-resistant bacteria
- Researchers use viral particles to trap intact mammalian protein complexes
- Study shows how different people respond to Aspirin
- Long-noncoding RNA regulates repair of DNA breaks in triple-negative breast cancer cells
| Radiation and immunotherapy combination can destroy both primary and secondary tumors Posted: 01 May 2016 11:25 AM PDT The addition of an immune system-strengthening compound to radiation therapy can extend the radiation therapy-induced immune response against the tumor sites and that this response even has an effect on tumors outside the radiation field. |
| New cancer drugs could treat lethal resistant prostate cancers Posted: 01 May 2016 11:25 AM PDT Men with aggressive prostate cancer that has stopped responding to conventional treatment could potentially benefit from a new class of cancer drug designed to overcome drug resistance, a new study suggests. Researchers found that the drugs, called Hsp90 inhibitors, specifically target and inactivate a mechanism commonly used by prostate cancer cells to evade the effects of standard treatment. |
| Screening method uncovers drugs that may combat deadly antibiotic-resistant bacteria Posted: 29 Apr 2016 10:35 AM PDT In recent years, hospitals have reported dramatic increases in the number of cases of the highly contagious, difficult-to-treat, and often deadly antibiotic-resistant bacteria carbapenem-resistant Enterobacteriaceae. Now, investigators have developed a promising method of identifying new antimicrobials that target these organisms. |
| Researchers use viral particles to trap intact mammalian protein complexes Posted: 29 Apr 2016 06:50 AM PDT Belgian scientists report their development of Virotrap, a viral particle sorting approach for purifying protein complexes under native conditions. This method catches a bait protein together with its associated protein partners in virus-like particles that are budded from human cells. Like this, cell lysis is not needed and protein complexes are preserved during purification. |
| Study shows how different people respond to Aspirin Posted: 28 Apr 2016 02:38 PM PDT Researchers have learned new information about how different people respond to aspirin, a globally prescribed drug in cardioprotection. The team identified more than 5,600 lipids in blood platelets and gained new insights into how these cells respond to aspirin. |
| Long-noncoding RNA regulates repair of DNA breaks in triple-negative breast cancer cells Posted: 28 Apr 2016 02:32 PM PDT Using a clinically guided genetic screening approach, researchers identified a non-coding RNA that is overexpressed in triple-negative breast cancer cells and regulated by the tumor suppressor p53 and the activated cell surface protein, EGFR. This molecule enhances the repair of DNA breaks by serving as a scaffold that links two other proteins in the repair machinery. |
| You are subscribed to email updates from Health & Medicine News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
ليست هناك تعليقات:
إرسال تعليق